You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

Filters
21 October 2021
On 15 October 2021 the TGA granted provisional approval to Roche Products Pty Ltd for its COVID-19 treatment - casirivimab + imdevimab (RONAPREVE) - making it the third COVID-19 treatment to receive regulatory approval in Australia.
21 October 2021

COVID-19 vaccines undergoing evaluation for provisional registration by the TGA

21 October 2021

Information about the TGA's safety monitoring of COVID-19 vaccines.

21 October 2021
This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
20 October 2021
The TGA has commenced proceedings in the Federal Court against Enviro Tech Holdings Pty Ltd, and its executive officers for the alleged unlawful importation of surgical face masks.
19 October 2021
A list of tests approved for inclusion in the Australian Register of Therapeutic Goods (ARTG)
19 October 2021

COVID-19 vaccine batch release information is now available.

18 October 2021

COVID-19 treatments that have been provisionally approved for use in Australia

18 October 2021

COVID-19 treatments undergoing evaluation for provisional registration by the TGA

18 October 2021

COVID-19 treatments that have received a provisional determination from the TGA

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us